Biomarkers and Peak Oxygen Uptake in Patients with Chronic Lung Disease | Zendy

Micha T. Maeder | Zendy; Martin Brutsche | Zendy; Nisha Arenja | Zendy; Thenral Socrates | Zendy; Miriam Reiter | Zendy; Julia Meißner | Zendy; Daniel Staub | Zendy; Nils G. Morgenthaler | Zendy; Andreas Bergmann | Zendy; Christian Mueller | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Biomarkers and Peak Oxygen Uptake in Patients with Chronic Lung Disease

Author(s) -

Micha T. Maeder,

Martin Brutsche,

Nisha Arenja,

Thenral Socrates,

Miriam Reiter,

Julia Meißner,

Daniel Staub,

Nils G. Morgenthaler,

Andreas Bergmann,

Christian Mueller

Publication year - 2010

Publication title -

respiration

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.264

H-Index - 81

eISSN - 1423-0356

pISSN - 0025-7931

DOI - 10.1159/000319038

Subject(s) - medicine , copeptin , cardiology , pulmonary function testing , respiratory disease , lung , obstructive lung disease , lung volumes , vo2 max , ventilation (architecture) , vital capacity , lung disease , gastroenterology , lung function , copd , diffusing capacity , heart rate , mechanical engineering , blood pressure , engineering , vasopressin

Peak oxygen uptake (peak VO(2)) is a predictor of outcome in patients with lung disease. In these patients, peak VO(2) is typically determined by ventilation and gas exchange. However, it is not well known whether cardiac strain contributes to peak VO(2) in patients with chronic lung disease.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research